Market Closed -
Nasdaq Stockholm
09:04:07 2024-05-07 am EDT
|
5-day change
|
1st Jan Change
|
69.4
SEK
|
-3.34%
|
|
-0.29%
|
+12.30%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,869
|
2,166
|
2,432
|
-
|
-
|
Enterprise Value (EV)
1 |
3,869
|
2,276
|
2,614
|
2,608
|
2,555
|
P/E ratio
|
-73.1
x
|
-15.6
x
|
-41.1
x
|
-104
x
|
51.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
9.7
x
|
10.9
x
|
10.2
x
|
7.95
x
|
EV / Revenue
|
-
|
10.2
x
|
11.7
x
|
11
x
|
8.35
x
|
EV / EBITDA
|
-
|
-29.9
x
|
-164
x
|
69.1
x
|
28.7
x
|
EV / FCF
|
-
|
-
|
-36.3
x
|
2,608
x
|
65.5
x
|
FCF Yield
|
-
|
-
|
-2.75%
|
0.04%
|
1.53%
|
Price to Book
|
-
|
-
|
8.27
x
|
9.33
x
|
7.53
x
|
Nbr of stocks (in thousands)
|
35,044
|
35,044
|
35,044
|
-
|
-
|
Reference price
2 |
110.4
|
61.80
|
69.40
|
69.40
|
69.40
|
Announcement Date
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
223.2
|
223
|
237.8
|
306
|
EBITDA
1 |
-
|
-76.07
|
-15.93
|
37.72
|
89
|
EBIT
1 |
-
|
-131.9
|
-51
|
-13.95
|
63
|
Operating Margin
|
-
|
-59.12%
|
-22.87%
|
-5.87%
|
20.59%
|
Earnings before Tax (EBT)
1 |
-
|
-147.2
|
-64
|
-24.48
|
50
|
Net income
1 |
-52.88
|
-138.4
|
-59
|
-23.22
|
47
|
Net margin
|
-
|
-62.01%
|
-26.46%
|
-9.77%
|
15.36%
|
EPS
2 |
-1.510
|
-3.950
|
-1.690
|
-0.6650
|
1.350
|
Free Cash Flow
1 |
-
|
-
|
-72
|
1
|
39
|
FCF margin
|
-
|
-
|
-32.29%
|
0.42%
|
12.75%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
2.65%
|
43.82%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
82.98%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
58.79
|
53
|
54
|
58
|
EBITDA
1 |
-1.501
|
-6
|
-2
|
5
|
EBIT
1 |
-12.87
|
-18
|
-14
|
-7
|
Operating Margin
|
-21.89%
|
-33.96%
|
-25.93%
|
-12.07%
|
Earnings before Tax (EBT)
1 |
-12.2
|
-22
|
-18
|
-11
|
Net income
1 |
-9.901
|
-21
|
-17
|
-11
|
Net margin
|
-16.84%
|
-39.62%
|
-31.48%
|
-18.97%
|
EPS
2 |
-0.2800
|
-0.6000
|
-0.5000
|
-0.3100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
110
|
182
|
175
|
123
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-1.445
x
|
-11.42
x
|
4.651
x
|
1.382
x
|
Free Cash Flow
1 |
-
|
-
|
-72
|
1
|
39
|
ROE (net income / shareholders' equity)
|
-
|
-32.6%
|
-18.3%
|
-10.9%
|
15.8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
8.390
|
7.440
|
9.220
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
7.19
|
12
|
10
|
12
|
Capex / Sales
|
-
|
3.22%
|
5.38%
|
4.21%
|
3.92%
|
Announcement Date
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +12.30% | 233M | | -29.70% | 3.15B | | -15.57% | 2.57B | | +21.75% | 2.55B | | +7.04% | 2.09B | | -1.13% | 2.04B | | -0.56% | 1.53B | | +2.15% | 1.33B | | +23.78% | 1.23B | | +4.72% | 1.16B |
Medical Supplies
|